SAN DIEGO — The U.S. Fish & Wildlife Service is sharing early results from the historic vaccine trial for highly pathogenic avian influenza (HPAI) in California condors.
As reported by the service's Incident Command leading the effort, results from the first test group showed that 60 percent of the condors produced measurable antibodies that are expected to provide partial protection against mortality from HPAI if the birds are exposed.
The trial, developed in coordination with the service, USDA and U.S. Geological Service was carried out by the Los Angeles Zoo, San Diego Zoo Wildlife Alliance, and the Oregon. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
